Batabulin clinical trials
Includes 2 studies of Batabulin sodium.
How each study uses batabulin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 1998 (1)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 1 |
| 2003 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic agents source
Studies
Open first, then newest update. How each study uses batabulin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous ChemotherapyStatus unknownPhase 2TularikNCT00022243Written as batabulin sodium
- T138067 Sodium in Treating Patients With Advanced Refractory CancerCompletedPhase 1Memorial Sloan Kettering Cancer CenterNCT00003359Written as batabulin sodium
- T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma PatientsTerminatedPhase 2/3TularikNCT00057382Written as T138067 intravenous
Codes
What other systems call batabulin · ClinicalTrials.gg INT004155
- MeSH (NLM) C119368batabulinOne source NLM
- UNII (FDA) T4NP8G3K6QBATABULINConfirmed FDA, NLM, Wikidata
- Wikidata Q27289662batabulinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72716BatabulinOne source FDA
- DrugBank DB16103One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C119368 | batabulin | One source NLM |
| UNII (FDA) | T4NP8G3K6Q | BATABULIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27289662 | batabulin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72716 | Batabulin | One source FDA |
| DrugBank | DB16103 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.